Home › Glioma › District of Columbia › Washington
Glioma clinical trials in Washington, DC
19 studies for Glioma are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
RecruitingPhase 1/2
- Children's National Medical Center, Washington D.C.
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
RecruitingPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RecruitingPhase 2
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
RecruitingPhase 2
- Children's National Medical Center, Washington D.C.
NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
RecruitingPhase 1
- Children's National Hospital, Washington D.C.
Targeted Pediatric High-Grade Glioma Therapy
RecruitingObservational study
- Children's National Medical Center, Washington D.C.
Study of Olutasidenib and Temozolomide in HGG
RecruitingPhase 2
- Children's National Medical Center, Washington D.C.
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
RecruitingPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
RecruitingPhase 2
- Children's National Medical Center, Washington D.C.
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
RecruitingPhase 1
- Children's National Medical Center, Washington D.C.
Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
RecruitingPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
RecruitingPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
RecruitingPhase 1/2
- Children's National Hospital, Washington D.C.
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RecruitingEarly phase 1Healthy volunteers welcome
- Children's National Medical Center, Washington D.C.
A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
RecruitingPhase 1
- Children's National Hospital, Washington D.C.
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RecruitingPhase 2
- Children's National Medical Center, Washington D.C.
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RecruitingPhase 1/2
- Sibley Memorial Hospital, Washington D.C.
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
RecruitingEarly phase 1
- Children's National Medical Center, Washington D.C.
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
RecruitingPhase 1
- National Institutes of Health, Bethesda · 7 mi away
Glioma trials in other cities
- New York City, NY25 studies
- Houston, TX23 studies
- Boston, MA20 studies
- Philadelphia, PA16 studies
- Columbus, OH15 studies
- Miami, FL15 studies
- San Francisco, CA14 studies
- Chicago, IL13 studies
- Durham, NC12 studies
- Seattle, WA11 studies
- St. Louis, MO10 studies
- Aurora, CO10 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.